88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet CHENGDU, China , May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study ... 2026-05-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet CHENGDU, China , May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology ... 2026-05-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO CHENGDU, China , May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) ... 2026-05-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanities At his first graduation as Dean, Patrick Tan presides over a record class of 135 graduates, with Guest of Honour Mdm Rahayu Mahzam and keynote speaker Dr Robert Califf ... 2026-05-30T Education Health Care/Hospital Higher Education Medical/Pharmaceuticals
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies BOSTON , May 29, 2026 /PRNewswire/ -- XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company ... 2026-05-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions SHANGHAI , May 29, 2026 /PRNewswire/ -- Innogen (HKEX: 2591), a biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for metabolic diseases, ... 2026-05-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health Expansion anchored by two top neurological health systems, structured AD biomarker data, and validated outcomes measures across neurological disease areas. Whole-population ingestion shifts NeuroBlu from ... 2026-05-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership SEOUL, South Korea , May 29, 2026 /PRNewswire/ -- South Korea-based medtech innovator SKIA has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ... 2026-05-29T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer ZEGFROVY ® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line treatment for advanced NSCLC with EGFR exon20ins WU-KONG28 is the first global ... 2026-05-29T Health Care/Hospital Medical/Pharmaceuticals
CooperVision Names Muru Annamalai as President, Asia-Pacific Experienced Global Healthcare Leader to Guide Growth Across the Region ... 2026-05-29T Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals